Showing results (451-460 of 867) with videos related to
Sort By:
Pageof 87
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|March 31, 2010
Acute kidney injury and renal replacement therapy independently predict mortality in neonatal and pediatric noncardiac patients on extracorporeal membrane oxygenationDavid J Askenazi, Namasivayam Ambalavanan, Kiya Hamilton, et al.Diabetes Care|December 24, 2004
Randomized effectiveness trial of a computer-assisted intervention to improve diabetes careRussell E Glasgow, Paul A Nutting, Diane K King, et al.Muscle & Nerve|September 6, 2019
Cross-sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatmentGary Cutter, Haichang Xin, Inmaculada Aban, et al.Journal of Public Health Dentistry|September 13, 2014
Prevalence and incidence of early childhood caries among African-American children in AlabamaTariq Ghazal, Steven M Levy, Noel K Childers, et al.Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|May 27, 2020
A Randomized Internet-Based Pilot Feasibility and Planning Study of Cherry Extract and Diet Modification in GoutJasvinder A Singh, Candace Green, Sarah Morgan, et al.Parkinsonism & Related Disorders|March 11, 2009
Weight changes associated with unilateral STN DBS and advanced PDHarrison C Walker, Michael Lyerly, Gary Cutter, et al.Journal of Rehabilitation Research and Development|July 30, 2015
VHA Multiple Sclerosis Surveillance Registry and its similarities to other contemporary multiple sclerosis cohortsWilliam J Culpepper, Mitchell T Wallin, Laurence S Magder, et al.Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 15, 2019
Patient-Centered Outcomes and Key Study Procedure Finalization in the Pilot Feasibility Gout Randomized Trial: Comparative Feasibility Study in GOUt, CHerry Extract Versus Diet Modification (Mini-GOUCH)Jasvinder A Singh, Amanda L Willig, Betty Darnell, et al.European Journal of Neurology|March 11, 2022
Evolution from a first clinical demyelinating event to multiple sclerosis in the REFLEX trial: Regional susceptibility in the conversion to multiple sclerosis at disease onset and its amenability to subcutaneous interferon beta-1aMarco Battaglini, Hugo Vrenken, Riccardo Tappa Brocci, et al.Neurology|July 12, 2020
A randomized, placebo-controlled, phase 2 trial of laquinimod in primary progressive multiple sclerosisGavin Giovannoni, Volker Knappertz, Joshua R Steinerman, et al.Pageof 87